Newsfeeds Archive - Page 2 of 2

1 minute read

Small-Cap ARCA Biopharma Stock Soars On Merger Pact: The Details

April 3, 10:00 AM

ARCA Biopharma and Oruka Therapeutics merge, focusing on novel biologics for chronic skin diseases like plaque psoriasis. ORKA-001 and ORKA-002 advance, supported by $275 million investment. Expect clinical trials in 2025. Merger closes Q3 2024. ABIO shares up 81.3% premarket."

ABIO

3 minute read

US Stocks Edge Lower; Private Employment Tops Views

By Avi Kapoor

April 3, 9:47 AM

U.S. stocks traded lower this morning, following the release of ADP jobs data on Wednesday. Following the market opening Wednesday, the Dow traded down 0.08% to 39,139.63 while the NASDAQ fell 0.27% to 16,197.58. The S&P 500 also fell, dropping, 0.02% to 5,204.61.

ABIO

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s Pre-Market Session

By Benzinga Insights

April 3, 8:09 AM

Gainers ARCA biopharma (NASDAQ:ABIO) stock moved upwards by 124.6% to $3.84 during Wednesday’s pre-market session. The market value…

ABIO

1 minute read

ARCA biopharma FY EPS $(0.69) Up From $(1.39) YoY; Cash & Cash Equivalents Of $42.4M Sufficient To Fund Its Operations Through The Middle Of 2024

By Benzinga Newsdesk

February 27, 4:22 AM

ARCA biopharma (NASDAQ:ABIO) reported quarterly losses of $(0.69) per share. This is a 50.36 percent increase over losses of $(1.39) per share from the same period last year.

ABIO

1 minute read

ARCA biopharma Q3 EPS $(0.16) Up From $(0.33) YoY

By Michael Horton

October 28, 4:16 PM

ARCA biopharma (NASDAQ:ABIO) reported quarterly losses of $(0.16) per share. This is a 51.52 percent increase over losses of $(0.33) per share from the same period last year.

ABIO

1 minute read

ARCA biopharma Q2 EPS $(0.22) Up From $(0.34) YoY

By Benzinga Newsdesk

August 2, 5:22 PM

ARCA biopharma (NASDAQ:ABIO) reported quarterly losses of $(0.22) per share. This is a 35.29 percent increase over losses of $(0.34) per share from the same period last year.

ABIO

Latest news

Small-Cap ARCA Biopharma Stock Soars On Merger Pact: The Details

US Stocks Edge Lower; Private Employment Tops Views

12 Health Care Stocks Moving In Wednesday’s Pre-Market Session

ARCA biopharma FY EPS $(0.69) Up From $(1.39) YoY; Cash & Cash Equivalents Of $42.4M Sufficient To Fund Its Operations Through The Middle Of 2024

ARCA biopharma Q3 EPS $(0.16) Up From $(0.33) YoY

ARCA biopharma Q2 EPS $(0.22) Up From $(0.34) YoY